Opportunity ID: 279762

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-AI-15-054
Funding Opportunity Title: Discovery/Development of Novel Therapeutics for Eukaryotic Pathogens (R21/R33)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.855 — Allergy and Infectious Diseases Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Oct 21, 2015
Last Updated Date:
Original Closing Date for Applications: Feb 10, 2016
Current Closing Date for Applications: Feb 10, 2016
Archive Date: Mar 12, 2016
Estimated Total Program Funding: $4,500,000
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
City or township governments
Native American tribal organizations (other than Federally recognized tribal governments)
Public housing authorities/Indian housing authorities
Small businesses
State governments
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Native American tribal governments (Federally recognized)
For profit organizations other than small businesses
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Independent school districts
Special district governments
Private institutions of higher education
Public and State controlled institutions of higher education
County governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Additional Information

Agency Name: National Institutes of Health
Description: The purpose of this FOA is to solicit applications to support early stage translational research focused on the discovery and development of novel therapeutics against select eukaryotic pathogens.
Link to Additional Information: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-15-054.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-C FORMS-C PKG00219288 Jan 10, 2016 Feb 10, 2016 View

Package 1

Mandatory forms

279762 RR_SF424_2_0-2.0.pdf

279762 PHS398_ResearchPlan_2_0-2.0.pdf

279762 PHS398_CoverPageSupplement_2_0-2.0.pdf

279762 RR_Budget_1_3-1.3.pdf

279762 RR_KeyPersonExpanded_2_0-2.0.pdf

279762 RR_OtherProjectInfo_1_3-1.3.pdf

279762 PerformanceSite_2_0-2.0.pdf

Optional forms

279762 PlannedReport-1.0.pdf

279762 PHS398_CumulativeInclusionReport-1.0.pdf

279762 RR_SubawardBudget30_1_3-1.3.pdf

2025-07-09T18:03:38-05:00

Share This Post, Choose Your Platform!

About the Author: